# University of Malaya

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-of-malaya/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 52.1 |
| Citations | 5,996,245 |
| City | Kuala Lumpur |
| Country | MY |
| Description | University of Malaya is a research organisation in Kuala Lumpur, MY. OpenAlex records 111,432 works and 5,996,245 citations for it. 25,955 researchers list it as their most recent affiliation. |
| Homepage | https://www.um.edu.my/ |
| OpenAlex ID | https://openalex.org/I33849332 |
| Region | Kuala Lumpur |
| Researchers | 25,955 |
| ROR ID | https://ror.org/00rzspn62 |
| Type | education |
| Works | 111,432 |

## University papers

Showing 12 of 65.

- [A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement](https://scholariq.org/papers/a-new-definition-for-metabolic-dysfunction-associated-fatty-liver-disease-an/)
- [Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-previously-untreated-pd-l1-expressing/)
- [The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease](https://scholariq.org/papers/the-asian-pacific-association-for-the-study-of-the-liver-clinical-practice/)
- [FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study](https://scholariq.org/papers/fibroscan-ast-fast-score-for-the-non-invasive-identification-of-patients-with/)
- [First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study](https://scholariq.org/papers/first-line-erlotinib-versus-gemcitabine-cisplatin-in-patients-with-advanced-egfr/)
- [Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis](https://scholariq.org/papers/diagnostic-accuracy-of-non-invasive-tests-for-advanced-fibrosis-in-patients-with/)
- [Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC](https://scholariq.org/papers/amivantamab-plus-lazertinib-in-previously-untreated-i-egfr-i-mutated-advanced/)
- [Factors associated with return to work of breast cancer survivors: a systematic review](https://scholariq.org/papers/factors-associated-with-return-to-work-of-breast-cancer-survivors-a-systematic/)
- [Global burden of metabolic diseases, 1990–2021](https://scholariq.org/papers/global-burden-of-metabolic-diseases-1990-2021/)
- [Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS](https://scholariq.org/papers/pan-asian-adapted-clinical-practice-guidelines-for-the-management-of-patients/)
- [Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial](https://scholariq.org/papers/tepotinib-plus-gefitinib-in-patients-with-egfr-mutant-non-small-cell-lung-cancer/)
- [Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study](https://scholariq.org/papers/targeted-prostate-cancer-screening-in-brca1-and-brca2-mutation-carriers-results/)

## University researchers

- [Chong Kin Liam](https://scholariq.org/researchers/chong-kin-liam/)
- [Hazreen Abdul Majid](https://scholariq.org/researchers/hazreen-abdul-majid/)
- [Adlinda Alip](https://scholariq.org/researchers/adlinda-alip/)
- [Mau Ern Poh](https://scholariq.org/researchers/mau-ern-poh/)
- [Yong Kek Pang](https://scholariq.org/researchers/yong-kek-pang/)
- [Raanita Krishnamoorthy](https://scholariq.org/researchers/raanita-krishnamoorthy/)

## University top topics

Showing 8 of 20.

- [Islamic Finance and Banking Studies](https://scholariq.org/topics/islamic-finance-and-banking-studies/)
- [Metal complexes synthesis and properties](https://scholariq.org/topics/metal-complexes-synthesis-and-properties/)
- [Linguistic, Cultural, and Literary Studies](https://scholariq.org/topics/linguistic-cultural-and-literary-studies/)
- [Advanced Fiber Optic Sensors](https://scholariq.org/topics/advanced-fiber-optic-sensors/)
- [Particle physics theoretical and experimental studies](https://scholariq.org/topics/particle-physics-theoretical-and-experimental-studies/)
- [Advanced Fiber Laser Technologies](https://scholariq.org/topics/advanced-fiber-laser-technologies/)
- [Conducting polymers and applications](https://scholariq.org/topics/conducting-polymers-and-applications/)
- [Metal-Organic Frameworks: Synthesis and Applications](https://scholariq.org/topics/metal-organic-frameworks-synthesis-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.